Study details
Enrolling now
Reducing Brain Metastases with MRI Monitoring
Wake Forest University Health Sciences
NCT IDNCT05692635ClinicalTrials.gov data as of Apr 2026
Phase
Phase 2
Target enrollment
60
Study length
about 3.8 years
Ages
18+
Locations
1 site in NC
What this study is about
This trial is testing if monitoring the brain with MRI after radiation therapy can help detect cancer spread to the brain before symptoms appear. It involves blood draws, MRI scans of the brain, and quality-of-life questionnaires.
Simplified from trial records by PatientMatch.
What you may be asked to do
- 1.Blood draws
- 2.Quality of Life Questionnaires
- 3.Take Gadolinium
- +1 more
Participation Burden
What's physically and logistically required of participants.
Logistics & Travel
In-person visits
Requires travel to a study site
Physical Intervention
Standard
How treatment is administered
Treatment Assignment
All receive treatment
Everyone gets the investigational treatment.
Extracted study details
Pulled from the trial record to show what is being tested and what the study is measuring.
Endpoints
Primary: Change in Central Nervous System Symptoms - Central Nervous System Symptom Scoring Form
Procedures
imaging
Body systems
Oncology